Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
07/2006
07/12/2006CN1802380A Use of vinca alkaloid and its salt
07/12/2006CN1802366A C-glycoside derivatives and salts thereof
07/12/2006CN1802351A Substituted 3-alkyl and 3-alkenyl azetidine derivatives
07/12/2006CN1802350A Azetidinecarboxamide derivatives and their use in the treatment of CB1 receptor mediated disorders
07/12/2006CN1802178A Solid formulation
07/12/2006CN1802167A Fusion proteins
07/12/2006CN1802166A Compositions for mucosal and oral administration comprising HCG fragments
07/12/2006CN1800221A Hydroxypropyl- sulfobutyl-beta- cyclodextrin and its preparation method, analytical method and pharmaceutical uses
07/12/2006CN1800185A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes.
07/12/2006CN1799604A Calcium-tonifying bone-strengthening medicine and preparation method thereof
07/12/2006CN1799602A Qi-invigorating, yin-nourishing medicinal pills and preparation method thereof
07/12/2006CN1799601A Blood lipid-lowering medicine and preparation method thereof
07/12/2006CN1799594A Medicine for treating cardiovascular and cerebrovascular disease and its preparing process
07/12/2006CN1799582A Blood sugar- and blood pressure-lowering medicine
07/12/2006CN1799571A Medicine for lowering blood sugar and treating women menopausal syndrome and preparation method thereof
07/12/2006CN1799551A Process for preparing glucose injection and glucose sodium chloride injection
07/12/2006CN1799549A Process for preparing soybean isoflavone phospholipid composition
07/12/2006CN1799548A Soybean isoflavone phospholipid composition and preparation method thereof
07/12/2006CN1799542A Hawthorn fruit total flavone phospholipid composition and its preparation method
07/12/2006CN1799541A Soybean isoflavone soft capsule and its preparation process
07/12/2006CN1799410A Diet fiber composition with blood lipid-reducing blood sugar-decreasing functions and its production method
07/12/2006CN1799407A Aloe and pollen tablet and its production method
07/12/2006CN1263842C New type health-care liquid from mashed onion and its preparation method
07/12/2006CN1263756C Imidazolepyrimidine derivatives and triazolopyrimidine derivatives
07/12/2006CN1263745C Aryl fused azapolycyclic compounds
07/12/2006CN1263734C Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
07/12/2006CN1263513C Emulsifying agent for preparing milky white cod liver oil
07/12/2006CN1263495C Pill for treating diabetes and preparation method thereof
07/12/2006CN1263492C Externally applied medicine for treating diabetes
07/12/2006CN1263489C Therapeutic and health-care medicinal hand bag
07/12/2006CN1263488C Capsule with ginseng and preparing technique
07/12/2006CN1263457C Orally disintegrating tablet of gypenosides and its preparation process
07/12/2006CN1263447C Stable solution of reduced coenzyme Q
07/12/2006CN1263398C Method for preparing vitamin B enriched products from herbal plant
07/12/2006CN1263397C High-calory liquid oral supplement
07/12/2006CN1263389C Tea of whiteflower red root and producing method
07/11/2006US7074940 Preparation of pharmaceutically acceptable atorvastatin salts in non-crystalline forms
07/11/2006US7074929 Certain alkylene diamine-substituted heterocycles
07/11/2006US7074925 N-substituted derivatives of 5-oxyiminobarbituric acid
07/11/2006US7074814 Antiinflammatory agents; cardiovascular disorders; anticancer agents; antiarthritic agents ; psoriasis
07/11/2006US7074811 for use in the treatment and/or prophylaxis of diabetes mellitus
07/11/2006US7074806 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders
07/11/2006US7074802 analgesics; antipyretics; antiinflammatory agents; antiarthritic agents
07/11/2006US7074801 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof
07/11/2006US7074800 Quinazoline derivatives as angiogenesis inhibitors
07/11/2006US7074799 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity
07/11/2006US7074798 Xanthine derivative and DPPIV inhibitor
07/11/2006US7074794 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor
07/11/2006US7074780 Substituted phenylcyclohexanecarboxamides and their use
07/11/2006US7074766 antiinflammatory agents; autoimmune diseases; thrombosis; viricides; blood disorders; antitumor agents
07/11/2006US7074617 MHC class II antigen-presenting systems and methods for activatind CD4+T cells
07/11/2006US7074437 comprises synthetic zeolite, protein extracts of nettle, milk vetch, balm, hop cones, and B-complex vitamins
07/11/2006US7074433 Process for the cure and control of Diabetes mellitus using natural products from Perna viridis
07/11/2006US7074408 Use of integrin antagonists to inhibit angiogenesis
07/11/2006US7074407 immunizing with fragments of CETP (cholesteryl ester transfer protein) which may be conjugated to a carrier, such as KLH (keyhole limpet hemocyanin) or ovalbumin, to increase immunogenicity
07/11/2006US7074406 Treating allergic diseases with humanized anti-CD40L antibody
07/11/2006US7074403 Immunotherapy of autoimmune disorders using antibodies which target B-cells
07/11/2006CA2376876C New isoindoloindolone derivatives, the process for preparing them and the pharmaceutical compounds that contain them
07/11/2006CA2355102C Antiparasitic formulations comprising doramectin
07/11/2006CA2344255C Novel derivatives of heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane, process for preparing them and pharmaceutical compositions containing them
07/11/2006CA2319201C Celecoxib compositions
07/11/2006CA2294670C Composition suitable as food integrator and for the treatment of intestinal disorders and alterations of the bacterial flora
07/11/2006CA2285548C Nicotinamide derivatives
07/11/2006CA2269810C N-substituted 2-cyanopyrrolidines
07/11/2006CA2215233C Terminal carboxy or tetrazole groups containing dialkyl ethers
07/11/2006CA2208630C 4-amino-2-ureidopyrimidine-5-carboxamides, processes for their preparation, pharmaceuticals comprising these compounds, and their use
07/11/2006CA2198751C Dihydro-2,3-benzodiazepine derivatives
07/11/2006CA2090584C Steroids having a methylene lactone group at position 17, process for preparing the same and their intermediates, use of the same as drugs and pharmaceutical compositions comprising the same
07/06/2006WO2006072054A1 Zinc-containing treatments for hyperphosphatemia
07/06/2006WO2006071752A1 Azolopyrimidine-based inhibitors of dipeptidyl peptidase iv and methods
07/06/2006WO2006071095A1 Quinazoline derivatives for the treatment and prevention of diabetes and obesity
07/06/2006WO2006070927A1 Pyrimidinylisoxazol derivative
07/06/2006WO2006070874A1 Hypoxic response promoter
07/06/2006WO2006070873A1 Adiponectin inducer or secretagogue
07/06/2006WO2006070856A1 Sesamin/episesamin compositions
07/06/2006WO2006070618A1 Catecholamine regulator and foods, drinks, food additives and drugs containing the same
07/06/2006WO2006070208A1 Pyridine, pyrimidine and pyrazine derivatives as gpcr agonists
07/06/2006WO2006070106A1 N-[(4, 5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, sulfonamide, carbamate and urea) derivatives as cannabinoid cb1 receptor antagonists
07/06/2006WO2006069809A1 Substituted indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their preparation and use in medicaments
07/06/2006WO2006069807A1 Substituted phenyl-piperazine compounds, their preparation and use in medicaments
07/06/2006WO2006069519A1 Solid dispersion of glibenclamide, its oral composition and methods
07/06/2006WO2006050314A3 Once a day formulation for phosphate binders
07/06/2006WO2006043036A3 Treatment of diabetes
07/06/2006WO2006035286A3 Process for preparating enantiomerically pure fluvastatin sodium and a novel polymorphic form thereof
07/06/2006WO2006030303A8 Oral extended release dosage form comprising a high dose biguanide and a low dose sulfonylurea
07/06/2006WO2005116002A3 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/06/2006WO2005077400A8 Cysteine rich peptides for improving thiol homeostasis
07/06/2006US20060149075 Crystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione
07/06/2006US20060149033 IGF antagonist peptides
07/06/2006US20060148875 Agent for prophylaxis and treatment of diabetic complications
07/06/2006US20060148862 Novel compounds that modulate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
07/06/2006US20060148840 Pyrrolodihydroisoquinolines as pde10 inhibitors
07/06/2006US20060148838 Novel pyrrolodihydroisoquinolines useful in the treatment of cancer
07/06/2006US20060148834 Novel coumarin-amide derivatives and its preparation, said drug composition and its use
07/06/2006US20060148825 1-[Alkyl], 1-[(heteroaryl) alkyl] and 1-[(Aryl)alkyl]-7-pyridinyl-imidazo[1,2-a]pyrimidin-5(1H)-one derivatives
07/06/2006US20060148819 Chemical compounds
07/06/2006US20060148802 Use of compounds that stimulate cgmp
07/06/2006US20060148798 Antiinflammatory agents; cardiovascular disorders; antidiabetic agents;central nervous system diosrders ; anticancer agents
07/06/2006US20060148794 Neuropeptide Y antagonist; antiarthritic agents; cardiovascular disorders; antidiabetic agents; kidney disorders; eating disorders; obesity
07/06/2006US20060148792 Substituted 1,4-benzodiazepines and uses thereof